City of Mart Defective Breast Mesh & Implant Injury Attorneys — Attorney911 (The Manginello Law Firm, PLLC) Pairs Ralph Manginello’s 27+ Years of Trial Experience with Lupe Peña’s Former Insurance Defense Strategy and Fluent Spanish — We Litigate Allergan BIOCELL (Recalled July 2019), Mentor MemoryGel, Sientra OPUS, AlloDerm, Strattice and GalaFLEX P4HB Scaffolds Under 21 CFR Parts 803, 807 and 814 — Handling BIA-ALCL CD30+/ALK- Pathology and MDL 2921 (Bellwether Oct 19, 2026) with Riegel Parallel-Claim Survivability in Western District of Texas Waco Division Claims — Applying Texas 2-Year Statute of Limitations and Discovery Rule Protections for Survivors in McLennan and Limestone Counties — $50M+ Recovered — Free Consultation, No Fee Unless We Recover Compensation for You, Hablamos Español, 1-888-ATTY-911
Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in City of Mart: The Definitive Guide for Patients and Families For many women in City of Mart, the journey through breast reconstruction or augmentation is an act of reclamation—a way to move forward after a breast cancer diagnosis, a prophylactic mastectomy for a BRCA1/BRCA2 mutation, or an aesthetic choice. However, for a growing number of patients in the City of Mart area and across McLennan County, that path has been marred by catastrophic complications linked to surgical mesh, acellular dermal matrix (ADM), and bioabsorbable scaffold products. If you are reading this in City of Mart because your reconstruction is failing, you are facing a new diagnosis of a device-associated cancer, or you are battling persistent infections, we want you to know that you are not alone, and the failure of these devices is not your fault. At The Manginello Law Firm, PLLC, operating under the consumer brand Attorney911, we represent women in City of Mart who have been harmed by medical devices that were cleared for the market without ever being proven safe for use in human breast tissue. Managing Partner Ralph Manginello, a Houston native with twenty-seven…